Zebrafish carrying myl4 or plakoglobin mutations have been used in small molecule screens to identify modifiers of cardiac arrhythmia, and have identified conserved disease mechanisms in both zebrafish and mammalian models [106,126,183,191]. This evidence concerns the gene MYL4 and chronic obstructive pulmonary disease.